GlaxoSmithKline has struck a deal worth around $2.1bn (£1.1bn) to acquire the global rights to the Danish biotech firm Genmab’s lead drug, a treatment for leukaemia.The two companies said today they had signed an agreement to co-develop and market HuMax-CD20, an experimental antibody treatment in late-stage development for CD20 chronic lymphocytic leukaemia (CLL) and non-Hodgkin’s […]
Shia militias linked to the radical cleric Moqtada al-Sadr pose the greatest threat to Iraq’s stability, a Pentagon report concluded yesterday.The report (pdf) said the Mahdi Army had eclipsed al-Qaida in Iraq in presenting “the greatest negative effect on the security situation”.
Five Bulgarian nurses and a Palestinian doctor were today sentenced to death by a court in Libya for deliberately infecting hundreds of children with the HIV virus.
The ruling immediately brought a chorus of international condemnation and could prove to be a setback for Libya’s efforts to improve ties with the West.
